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Abstract
Introduction Macrophages in the mammary gland are essential
for morphogenesis of the ductal epithelial tree and have been
implicated in promoting breast tumor metastasis. Although it is
well established that macrophages influence normal
mammopoiesis, the mammary cell types that these accessory
cells influence have not been determined. Here we have
explored a role for macrophages in regulating mammary stem
cell (MaSC) activity, by assessing the ability of MaSCs to
reconstitute a mammary gland in a macrophage-depleted fat
pad.
Methods Two different in vivo models were used to deplete
macrophages from the mouse mammary fat pad, allowing us to
examine the effect of macrophage deficiency on the mammary
repopulating activity of MaSCs. Both the Csf1op/op mice and
clodronate liposome-mediated ablation models entailed
transplantation studies using the MaSC-enriched population.
Results We show that mammary repopulating ability is severely
compromised when the wild-type MaSC-enriched
subpopulation is transplanted into Csf1op/op fat pads. In
reciprocal experiments, the MaSC-enriched subpopulation from
Csf1op/op glands had reduced regenerative capacity in a wild-
type environment. Utilizing an alternative strategy for selective
depletion of macrophages from the mammary gland, we
demonstrate that co-implantation of the MaSC-enriched
subpopulation with clodronate-liposomes leads to a marked
decrease in repopulating frequency and outgrowth potential.
Conclusions Our data reveal a key role for mammary gland
macrophages in supporting stem/progenitor cell function and
suggest that MaSCs require macrophage-derived factors to be
fully functional. Macrophages may therefore constitute part of
the mammary stem cell niche.
Introduction
Increasing evidence suggests that macrophages play a role in
the normal development of specific organs. In the pubertal
mammary gland, macrophages are recruited to the highly
mitotic terminal end buds (TEBs) from which ducts elongate
and branch to give rise to a mature ductal tree. Macrophages
are presumed to play a role in tissue remodeling by engulfing
apoptotic epithelial cells during ductal morphogenesis [1,2].
Colony stimulating factor-1 (Csf1; also referred to as macro-
phage-Csf) is a key growth factor that regulates the prolifera-
tion and survival of macrophages [3]. Csf1op/op mice,
homozygous for a null mutation in Csf1, exhibit multiple
defects and have reduced macrophage numbers in most tis-
sues including the mammary gland. These mice are severely
runted, toothless and osteopetrotic, owing to an osteoclast
deficiency that impairs bone resorption. The mammary glands
of Csf1op/op mice display lower numbers of terminal end buds
as well as reduced ductal branching and elongation [4]. Dur-
ing pregnancy, Csf1op/op glands develop precocious alveolar
units but fail to switch to the lactational state resulting in
impaired lactation [5]. Mammary-specific rescue has shown
that the mammary gland phenotype is not due to secondaryPage 1 of 6
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ablation of the receptor for Csf1 (Csf1r or c-fms), recapitu-
lated all the phenotypes observed in Csf1op/op mice, although
the receptor-null mice exhibited slightly more severe defects
[7].
The nature of the mammary stem cell niche is yet to be defined
but candidate cell types that may constitute the niche include
epithelial cells, macrophages and eosinophils, among other
cells in the mammary stroma (fibroblasts and adipocytes). One
mechanism that may underlie the requirement of macrophages
for normal mammopoiesis could be their interaction with mam-
mary stem cells (MaSCs) [8,9]. To explore this possibility, we
have utilized two in vivo approaches to determine whether
macrophages are required for the function of MaSCs. We
report that stem/progenitor cell activity is markedly attenuated
by depletion of macrophages from the mammary gland, indi-
cating that macrophages may influence stem cell function.
Materials and methods
Mouse strains
Csf1op/op mice were a kind gift from Dr Robin Anderson (Peter
MacCallum Cancer Centre, Melbourne, Australia) and were on
a pure BALB/c background. These mice were housed in a
clean facility to optimise the viability of the homozygous mutant
mice. Rosa26 mice were on a pure FVB/N background. All
experiments were approved by the WEHI Animal Ethics Com-
mittee, and the care of animals was in accordance with institu-
tional guidelines.
Mammary stem cell preparation and cell culture
A single cell suspension of mammary cells was prepared from
freshly harvested mammary glands and sorted by flow cytom-
etry as previously described [8]. For transplantation assays,
freshly harvested cells from the Lin-CD29hiCD24+ fraction
were transplanted in a volume of 10 μl into the de-epithelial-
ized fourth mammary fat pads of three week-old syngeneic
mice. Limiting dilution and statistical analyses were carried out
as described by Shackleton et al [8]. For experiments using
liposomes, the injection solution contained approximately 42
μg of clodronate liposomes per injection volume. Wholemount
and histology analyses, as well as staining of mammary glands
for LacZ activity using X-Gal (Sigma), were performed as
described [8]. Clodronate liposomes were synthesized as pre-
viously described [10].
For in vitro cell culture assays, 100 freshly sorted epithelial
cells (56 cells/cm2) were cultured for one week on 25,000
irradiated NIH-3T3 fibroblasts (14,000 cells/cm2) in 24-well
culture dishes as described [8]. Colony size was measured
using ImageJ [11].
Results
To evaluate whether the impaired ductal morphogenesis that
occurs in Csf1op/op mice (Figure 1a) reflects a perturbation in
MaSC activity, freshly sorted CD29hiCD24+ mammary epithe-
lial cells were isolated from BALB/c Csf1op/op and wild-type
glands. They were then transplanted into the de-epithelialized
fat pads of three-week-old BALB/c mice at limiting dilution.
The CD29hiCD24+ subpopulation has previously been shown
to be enriched for MaSCs but also contains mature myoepi-
thelial cells and possibly basal progenitor cells [8]. Cells were
purified from 12 week-old Csf1op/op mice and eight-week-old
wild-type littermates, in order to compensate for the recog-
nised delay in filling of the fat pad that occurs in Csf1op/op
mutant mice [4]. The glands were harvested for wholemount
analysis eight weeks post-transplantation.
Limiting dilution analysis of four independent experiments
revealed that the stem cell frequency was reduced in Csf1op/
op mice. The mammary repopulating frequency was 1 in 261
(95% confidence interval (CI) = 1/166 to 1/408) versus 1 in
97 (95% CI = 1/66 to 1/141) for Csf1op/op and wild-type mam-
mary glands, respectively (P < 0.001; Table 1). Estimation of
the absolute number of mammary repopulating cells revealed
an 18-fold decrease in mutant glands (mean of 702 versus 40
cells per gland in wild-type and Csf1op/opmice, respectively). In
addition to the decrease in repopulating frequency by
CD29hiCD24+ cells in the Csf1op/op group, only 5 of the 45
transplanted fat pads (11 ± 4%; mean ± standard error of the
mean (SEM)) yielded outgrowths filling more than 50% of the
fat pad, whereas 22 of the 45 transplanted fat pads (49 ± 4%)
were filled by outgrowths from wild-type stem cells. Thus,
despite being transplanted into a normal microenvironment,
the MaSC-enriched population from Csf1op/op mice did not
give rise to fully developed mammary outgrowths (Figure 1b),
indicating that the function of mammary stem/progenitor cells
had been attenuated in the macrophage-depleted environ-
ment.
Consistent with the transplantation data, in vitro colony form-
ing assays on fibroblast feeder layers revealed a two-fold
reduction in the clonogenic potential of CD29hiCD24+ cells
from Csf1op/op mice relative to those from control mice (Figure
1c). The absolute numbers of clonogenic cells in the MaSC-
enriched population per mammary gland from either wild-type
or Csf1op/opmice were estimated to be 14,666 ± 1530 and
1306 ± 348, respectively (mean ± SEM, n = 3). Notably, a
2.4-fold decrease in colony size was also apparent on compar-
ison of colonies derived from Csf1op/op CD29hiCD24+ cells rel-
ative to those from wild-type mice. The addition of F4/80-
positive mouse mammary macrophages to the clonogenic
assays had no discernible effect on colony size or morphology,
but may reflect inadequate culture conditions for macro-
phages in the epithelial cell assays (data not shown).
To investigate a potential role for macrophages in the mam-
mary stem cell microenvironment, the wild-type MaSC-
enriched population was next transplanted into the macro-
phage-deficient fat pads of Csf1op/op mice. Two hundredPage 2 of 6
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young wild-type female mice (BALB/c) were transplanted into
either three-week-old wild-type or six-week-old Csf1op/op fat
pads that had been cleared of endogenous epithelium. Older
mutant recipient mice were used to compensate for the
marked developmental delay that occurs in Csf1op/op mice.
Substantial outgrowths were observed in wild-type recipients
(18 of 24), whereas only a single small outgrowth (1 of 18)
comprising two ducts was evident in Csf1op/op recipients (P <
0.00001; Figures 2a, b). These data suggest that mammary
repopulating cells require the presence of resident macro-
phages in the mouse mammary gland.
To further investigate the effect of macrophage depletion from
the mammary fat pad on stem cell activity, an alternative model
of macrophage deficiency was sought. Clodronate is a
bisphosphonate that can be delivered in a targeted manner
when packaged into liposomes [10]. The liposomes are non-
Figure 1
The MaSC-enriched population from Csf1op/op mice yields smaller outgrowths in vivo and has lower clonogenicity in vitrol i fr  f op/op ice yields s al er outgrowths in vivo and has lower clonogenicity in vitro. (a) Wholemounts of fourth 
mammary glands from eight-week-old wild-type and Csf1op/op mice showing delayed filling of the fat pad and persistence of terminal end buds in 
mutant animals. (b) Wholemounts of outgrowths following transplantation of CD29hiCD24+ cells from wild-type or Csf1op/op mammary glands into 
the cleared fat pads of syngeneic wild-type recipients. (c) CD29hiCD24+ cells from Csf1op/op mammary glands exhibit lower clonogenicity and col-
ony size than those from control glands. Histogram (upper panel) showing colony forming capacity of 100 CD29hiCD24+ cells for each genotype. 
Error bars show standard error of the mean for three independent experiments. Lower panel shows cultures of CD29hiCD24+ cells grown on fibrob-
last feeder layers. Scale bars = 1 mm. Csf1 = colony stimulating factor 1; MaSC = mammary stem cell.Page 3 of 6
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down by liposomal phospholipases to reveal the drug. Suffi-
cient clodronate uptake by macrophages causes cell death by
apoptosis. In co-transplantation experiments, CD29hiCD24+
cells (200 cells) from the mammary glands of Rosa26 mice
were coinjected into the cleared mammary fat pads with either
clodronate-containing or saline-containing (control) lipo-
somes. Six weeks after transplantation, the glands were har-
vested and the outgrowths analysed by staining for LacZ
activity (see Materials and methods). Three independent
experiments revealed outgrowths in 22 of 28 (77 ± 5%) fat
pads coinjected with saline liposomes compared with only 4
of 28 (18 ± 10%) fat pads co-injected with clodronate-con-
taining liposomes (P < 0.000001). Of the four outgrowths evi-
dent in the clodronate group, only one branching outgrowth
was observed, while the remaining three were very rudimen-
tary structures (Figure 2c).
Discussion
Our data reveal that mammary macrophages contribute to nor-
mal stem/progenitor cell function in the developing mouse
mammary gland. In a macrophage-deficient environment, the
MaSC-enriched subpopulation had a markedly diminished
capacity to reconstitute mammary outgrowths. The role of
macrophages in this organ, however, appears to be supportive
rather than integral to MaSC function, because these mice
harbor some MaSCs and limited development can occur in
Csf1op/op mice. Interestingly, even in a macrophage-replete
system, the function of MaSCs from Csf1op/op glands was
compromised. Indeed, both the absolute number and repopu-
lating capability of MaSCs appear to have been altered by the
macrophage-deficient environment, possibly reflecting down-
regulation of growth factor-mediated signal transduction path-
ways required for stem cell function.
Here we demonstrate the efficacy of clodronate-containing
liposomes for macrophage depletion in the mammary gland.
Clodronate liposomes have been successfully utilized for mac-
rophage depletion from liver, spleen, lung, lymph nodes, joints,
peritoneal cavity, and testis [10]. Local depletion of resident
macrophages from the developing mammary gland by clodro-
nate liposomes led to a marked decrease in repopulation by
the MaSC-enriched fraction. The depletion of macrophages is
likely to be temporary as the liposomes are phagocytosed
within the first few days and macrophages presumably return
to normal levels by the time of tissue harvest at six weeks post-
transplantation. Therefore, mammary macrophages appear to
be required for the early stages of repopulation by MaSCs and
their progeny.
It is tempting to speculate that mammary macrophages consti-
tute part of the normal MaSC microenvironment and facilitate
the maintenance and/or proliferation of stem cells. Gene
expression analysis has shown that the MaSC-enriched sub-
population expresses significantly higher levels of Csf1
(approximately five-fold by quantitiative RT-PCR) relative to the
luminal epithelial subset. Only macrophages in the mammary
gland appear to express the receptor (c-fms or Csf1R) for the
Csf1 ligand under normal physiologic conditions, based on
immunostaining for the receptor [4] as well as expression in c-
fms reporter mice (data not shown). Csf1 may therefore be a
chemoattractant for macrophages to the niche in which
MaSCs are thought to reside in a basal location. Consistent
with this notion, macrophages can be found around the cap
cell region of TEBs [4], which has been proposed to be
enriched for stem cells [12]. The factors released by macro-
phages that support stem cell activity are yet to be determined
but may include macrophage-secreted cytokines such as
CXCL12. Evidence for the direct participation of macro-
phages in the MaSC niche should eventually be possible
through the prospective identification of a highly specific
Table 1
Limiting dilution analysis of wild-type or Csf1op/op CD29hiCD24+ cells transplanted into cleared mammary fat pads
Number of CD24+CD29hi cells injected per fat pad Number of positive outgrowths*
Wild-type Csf1op/op
60 3/4 0/4
100 7/11 5/11
120 2/4 1/4
200 20/22 12/22
240 3/4 2/4
Repopulating frequency
(95% confidence interval)
1/97
(1/66 to 1/141)
1/261
(1/166 to 1/408)
Limiting dilution analysis of the repopulating frequency of mammary stem cell (MaSC)-enriched cells from either wild-type or Csf1op/op glands 
transplanted into wild-type recipients. Cells were injected into the cleared mammary fat pads of three-week-old syngeneic recipients. Results are 
pooled from four independent experiments (P = 0.00065). *Shown as number of outgrowths per number of injected fat pads. Csf1 = colony 
stimulating factor 1.Page 4 of 6
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at the base of the crypts allowed the localization of macro-
phages to this region, while electron microscopy identified a
direct physical relation between colonic epithelial progenitor
cells and macrophages [13].
Conclusions
Our data demonstrate that depletion of mammary gland mac-
rophages either by chemical ablation or the use of Csf-1op/op
mutant mice alters mammary stem/progenitor cell activity,
reflected in a substantially reduced repopulating frequency.
The diminished outgrowth potential indicates a continued
requirement for normal macrophages during ductal morpho-
genesis and may be mediated by effects on the putative basal
progenitor cell. Overall, these findings indicate that macro-
phages play a role in supporting normal mammary stem cell
function in vivo and suggest that they may constitute part of
the normal MaSC microenvironment.
Figure 2
Wild-type mammary stem cells are unable to efficiently repopulate macrophage-deficient fat pads. (a) Wild-type CD29hiCD24+ cells transplanted 
into Csf1op/op fat pads resulted in only a single small outgrowth whereas those transplanted into wild-type recipients resulted in extensive filling of the 
fat pad, all harvested at eight weeks post-transplantation. (b) Histogram showing percent outgrowth and the extent of fat pad filling following trans-
plantation of normal CD29hiCD24+ cells into wild-type or Csf1op/op fat pads. Error bars represent standard error of the mean for three independent 
experiments. (c) Clodronate liposomes inhibit mammary stem cell function. CD29hiCD24+ cells (200) from Rosa26 mice were co-transplanted with 
liposomes containing either saline or clodronate into the cleared mammary fat pads of syngeneic wild-type female mice. The cells co-transplanted 
with clodronate liposomes resulted in no outgrowths or rudimentary structures, an example of which is shown. Scale bars = 1 mm. Csf1 = colony 
stimulating factor 1.Page 5 of 6
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